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Abstract: Extracellular vesicles (EVs), including exosomes, microvesicles, and apoptotic bodies, are
cell-derived membranous structures that were originally catalogued as a way of releasing cellular
waste products. Since the discovery of their function in intercellular communication as carriers of
proteins, lipids, and DNA and RNA molecules, numerous therapeutic approaches have focused on the
use of EVs, in part because of their minimized risk compared to cell-based therapies. The skin is the
organ with the largest surface in the body. Besides the importance of its body barrier function, much
attention has been paid to the skin in regenerative medicine because of its cosmetic aspect, which
is closely related to disorders affecting pigmentation and the presence or absence of hair follicles.
The use of exosomes in therapeutic approaches for cutaneous wound healing has been reported and
is briefly reviewed here. However, less attention has been paid to emerging interest in the potential
capacity of EVs as modulators of hair follicle dynamics. Hair follicles are skin appendices that mainly
comprise an epidermal and a mesenchymal component, with the former including a major reservoir
of epithelial stem cells but also melanocytes and other cell types. Hair follicles continuously cycle,
undergoing consecutive phases of resting, growing, and regression. Many biomolecules carried
by EVs have been involved in the control of the hair follicle cycle and stem cell function. Thus,
investigating the role of either naturally produced or therapeutically delivered EVs as signaling
vehicles potentially involved in skin homeostasis and hair cycling may be an important step in the
attempt to design future strategies towards the efficient treatment of several skin disorders.
Keywords: extracellular vesicles; exosomes; apoptotic bodies; skin; hair follicles; hair cycle; stem
cells; immune cells
1. Introduction
The skin is the largest organ in the body in terms of extension (1.5–2 m2 in humans) and comprises
around 16% of total bodyweight [1]. As the major body barrier, it plays an essential role in both
stimuli sensing and defense against environmental insults and pathogens. The outer skin layer is the
epidermis, a stratified epithelium of ectodermal origin with a high turnover rate. It is mainly built by
keratinocytes but also contains other cell types, such as melanocytes, Merkel cells, and Langerhans
cells, which are involved in pigmentation, sensing, and immune response, respectively. Resting below
the epidermal basal membrane is the dermis, a mesenchymal layer of connective tissue containing
collagen fibers and fibroblasts as well as blood vessels and nerve endings. Finally, the composition
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of the subjacent hypodermal tissue is dependent on the part of the body (e.g., fat, connective tissue,
bone). Skin appendices include hair follicles (HFs) and glands. HFs are important for warmth function
in mammals but also account for social and cosmetic features in humans. The HF cycle continuously
occurs over the life of the organism, involving successive phases of rest (telogen), growth (anagen),
and regression (catagen) [2] (Figure 1). Directly below the sebaceous gland and at the level of insertion
of the piloerector muscle, the HF bulge, which hosts a major reservoir of skin stem cells (SCs), is
located [3]. Due to ease of accessibility and knowledge collected about the location and function of skin
SCs, the skin in general, and the HF in particular, have drawn much attention as targets for regenerative
treatments. Among these, the use of extracellular vesicles as a safer alternative in comparison with
cell-based approaches is gaining importance.
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catenin (green) and BMP/Smad (red) signals, which mainly emanate from the dermal papilla and 
control the behavior of follicular epithelial cells. Several factors and molecules have been found to 
affect different steps of the cycle, including Sonic hedgehog (Shh), Noggin, FGF-7, and reactive 
oxygen species (ROS), which work as inductors of growth; TGFβ-1, which is involved in catagen 
onset; and FGF-18, which regulates telogen. The role of extracellular vesicles (EVs) in skin has been 
assessed to date with a major focus on their effects on the wound healing process but suggesting 
substantial effects on hair cycling. For instance, EVs containing Wnt3a, Wnt11, Wnt4, β-catenin, and 
14-3-3 proteins may contribute to hair growth by enhancing Wnt signaling; HSP70 containing 
exosomes have been related to pigmentation defects; and the routes involving Pi3K/AKT, 
MAPK/ERK, STAT3, and IGF1 have been connected with exosome-mediated effects in skin, therefore 
becoming potential targets for EV-mediated therapeutic approaches. 
Extracellular vesicles (EVs) comprise a heterogeneous variety of membrane-enclosed structures 
in terms of size, mechanisms of biogenesis, composition, cargo, and functions. They contain 
transmembrane proteins and enclose components derived from the donor cell that may include 
Figure 1. Regulation of the hair follicle cycle. Hair follicles continuously cycle, undergoing consecutive
phases of growing (anagen), regression (catagen), and resting (telogen). The fine regulation of hair
follicle dynamics globally depends on the coordinated alternation between Wnt/β-catenin (green) and
BMP/Smad (red) signals, which mainly emanate from the dermal papilla and control the behavior
of follicular epithelial cells. Several factors and molecules have been found to affect different steps
of the cycle, including Sonic hedgehog (Shh), Noggin, FGF-7, and reactive oxygen species (ROS),
which work as inductors of growth; TGFβ-1, which is involved in catagen onset; and FGF-18, which
regulates telogen. The role of extracellular vesicles (EVs) in skin has been assessed to date with
a major focus on their effects on the wound healing process but suggesting substantial effects on
hair cycling. For instance, EVs containing Wnt3a, Wnt11, Wnt4, β-catenin, and 14-3-3 proteins may
contribute to hair growth by enhancing Wnt signaling; HSP70 containing exosomes have been related
to pigmentation defects; and the routes involving Pi3K/AKT, MAPK/ERK, STAT3, and IGF1 have been
connected with exosome-mediated effects in skin, therefore becoming potential targets for EV-mediated
therapeutic approaches.
Extracellular vesicles (EVs) comprise a heterogeneous variety of membrane-enclosed structures
in terms of size, mechani ms of biogenesis, composition, cargo, and functions. Th y contain
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transmembrane proteins and enclose components derived from the donor cell that may include
proteins, lipids, and DNA and RNA molecules [4–6]. Most types of cells can secrete EVs, from bacterial
to animal—including human—to plant cells, which suggests that such an evolutionary conserved
mechanism [7] could be playing an essential role in cellular function. EVs can be isolated from
body fluids or cell culture supernatants and are nowadays becoming central signaling vehicles and
critical players in cell-cell communication, thus being implicated in physiological and pathological
processes [8].
According to their route of biogenesis, EVs are generally classified into three subtypes, namely,
exosomes, microvesicles, and apoptotic bodies, with the former having been more frequently connected
to skin regenerative processes. Exosomes are 30–150 nm vesicles which originate via the endocytic
pathway. Normally, inward budding of the plasma membrane or fusion of vesicles gives rise to early
endosomes, which in turn can undergo inward budding, forming so-called multivesicular bodies
(MVBs). The intraluminal vesicles created by this process can either be directed to degradation in late
endosomes, involving lysosomes, or can be secreted to the extracellular space by exocytosis, which is
mediated by the fusion of MVBs with the plasma membrane [9,10]. Since the first characterization of
exosomes in the 1980s [11,12] and in light of later studies proving their role beyond the clearance of
waste products as immune players and even as anti-tumor vaccines [13,14], much research has been
directed at understanding their mechanisms of biogenesis. It is well established that Rab GTPase
family members play a key role in the modulation of exosome secretion, mainly along the pathway that
involves Endosomal Sorting Complexes Required for Transport (ESCRT), though the process can also
occur in an ESCRT-independent manner, in which tretraspanins (CD81, CD9, and CD63) and lipids play
a crucial role [7,10]. Microvesicles are larger lipid bilayer membrane-enclosed structures (0.1–1 µm)
which originate via outward budding of the cell membrane. Although their mechanism of formation
has not yet been uncovered in detail, it is known to involve a rearrangement of plasma membrane
phospoholipids, enzymatic processes, and cytoskeletal-mediated contraction, which eventually allows
for the fission of the membrane protrusions. Finally, relatively large (up to several microns) apoptotic
bodies are formed by outward blebbing of the plasma membrane of apoptotic cells, meaning they
usually contain cellular fragments [15]. Despite the increasing consensus about EV classification, it
is hard to distinguish them once they reach the extracellular space. Their interaction with recipient
cells can occur in different ways: ligand-receptor interaction; internalization by clathrin-dependent
endocytosis, caveolin-mediated uptake, macropinocytosis, or phagocytosis mediated by specific
receptors; and direct fusion with the plasmatic membrane of the recipient cell, thereby involving the
release of EV content in the cytoplasm of the recipient cell [16]. These processes can affect a number
of key cellular signaling pathways that modulate essential cellular processes, such as proliferation,
differentiation, migration, and cell death.
2. Extracellular Vesicles in Cutaneous Regenerative Medicine
2.1. Use of Extracellular Vesicles to Boost Skin Regeneration
The skin wound healing process comprises four stages: (1) hemostatic, (2) inflammatory,
(3) proliferative, and (4) remodeling [17,18]. During this process, the skin is sequentially: (1) activated
to recruit repairing cell types; (2) cleaned of pathogens by the immune system; (3) stimulated to
provoke the proliferation of fibroblasts and the production of the extracellular matrix; and (4) closed by
the structural adjustment of the newly produced extracellular matrix. EVs obtained from a plethora of
cell types, mainly including mesenchymal stem cells (MSCs) of different origin, but also dermal papilla
(DP) cells, amniotic epithelial cells, keratinocytes, and endothelial progenitors, among others, have
been tested within different models of skin injury, such as skin wounds in healthy and diabetic rodents
or severe burns in rats (as reviewed in [17,19,20]). Key steps of the healing process have been proven to
benefit from the action of EVs, including cell proliferation, migration [21–25], angiogenesis [22,26–29]
and collagen deposition [22,25,28–30], and are mainly mediated by enhanced AKT/ERK and Wnt
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signaling. Overall, the effects of EVs can be summarized in accelerated wound healing and reduced
scar formation.
Additionally, it has been suggested that multipotent neural SCs obtained from HFs can serve
as exosome producers, based on the beneficial effects of a conditioned medium for the treatment of
ischemia-reperfusion-induced lung injury in a rat model [31]. Hence, HFs can also be postulated as a
source of exosome-producing SCs.
However, robust conclusions and defined clinical protocols are still hard to define because of the
lack of consensus regarding the source of EVs used in different studies, the models chosen to test EV
treatments, and the methods used for EV delivery. Additionally, the technical procedures used to isolate,
purify, and quantify exosomes and microvesicles, which have been fairly extensively reviewed [32],
are indeed a crucial point to consider in order to allow data standardization. For these reasons, the
molecular mechanisms of the action of EVs in wound healing need to be further characterized, with
special attention paid to simultaneous effects on hair growth.
2.2. Regulation of the Pigmentation Process by Exosomes
The cell population of melanocytes, which are resident in the skin but originate at the neural crest
during embryonic development [33], accounts for skin and hair pigmentation. It has been suggested
that cytosolic proteins, such as the heat shock 70 kDa protein (HSP70) chaperone, can be recruited and
sequestered in exosomes as a mere consequence of their physical interaction with other proteins [7].
The role of HSP70 in progressive depigmentation has been confirmed in vivo using a mouse model of
autoimmune vitiligo [34]. Vitiligo is an autoimmune disorder that involves progressive depigmentation
mediated by a T-cell response to melanocytes. The amount of HSP70 is increased in the supernatant of
vitiligo versus the control melanocytes, and, when secreted into the extracellular space by melanocytes,
HSP70 interacts with antigen-presenting dendritic cells, enhancing their uptake and processing of
antigens. This leads to the activation of T-cells, which are ultimately responsible for the loss of
HSP70-producing melanocytes. The mouse model used by Denman and colleagues was based on the
introduction by gene gun vaccination of eukaryotic plasmids encoding melanocyte differentiation
antigens. When combined with the vaccination protocol, the introduction of inducible HSP70 resulted
in significantly accelerated depigmentation. In addition, this protein is found in exosomes derived
from most cell types and it is therefore likely to occur in exosomes from melanocytes. In light of
these observations, it is tempting to speculate that the release of HSP70-containing vesicles to the
extracellular milieu by melanocytes may contribute to the disease.
Importantly, not only can the exosomes potentially secreted by melanocytes affect the pigmentation
process, but also signaling molecules carried by exosomes originating in other cell types resident in
the skin could affect melanocytes. In this regard, one sophisticated study has compared the effects of
exosomes obtained from human keratinocytes of different skin phototypes to stimulate melanocyte
function, as well as the potential of ultraviolet B (UVB) light to modulate this capacity. Interestingly,
the expression of key proteins participating in the pigmentation process, such as the enzyme tyrosinase,
the melanocyte isoform of microphthalmia-associated transcription factor (MITF), which is the master
transcriptional regulator of melanogenesis, and the Rab27a protein, involved in the mobilization of
melanosomes, were proven to be increased in melanocytes in the presence of exosomes either obtained
from Caucasian donors and treated with UVB, or obtained from black donors [35]. This groundbreaking
work demonstrated for the first time that miRNAs contained in exosomes secreted by keratinocytes
have the ability to modulate pigmentation. On the other hand, another study has reported the ability of
keratinocyte exosome-derived miR-675 to decrease MITF levels in melanocytes [36]. Altogether, these
observations may prompt new strategies for modulating skin pigmentation and hair pigmentation
through the potential effects driven by exosomes on HF bulge resident melanocyte precursors.
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3. Role of Extracellular Vesicles in Hair Follicle Function
One previous study focused on rodent incisors found evidence of exosomes mediating
epithelium-mesenchyme molecular crosstalk [37]. Since the HF is considered one of the prototypical
systems for epithelial-mesenchymal crosstalk, it can be postulated as a top candidate to benefit from
EV-based clinical approaches. Moreover, regenerative hair waves continuously occur over mice
lifetimes and it has been demonstrated that the cycling rhythm declines with age, although it is possible
to rescue the cycling capability by transplanting aged skin into a younger donor [38]. In addition,
transplanted DP cells are able to induce hair growth [39,40]. In sum, these observations suggest that
hair growth induction is rather dependent on secreted factors than a cell-autonomous process.
3.1. Effects of Extracellular Vesicles on Hair Follicle Dynamics
3.1.1. Exosomes as Signaling Mediators with the Potential to Modulate Hair Cycling
Bone morphogenetic proteins (BMP), which emanate from dermal cells and adipocytes, maintain
SC quiescence during telogen [3]. Interestingly, DP cells undergo oscillating and out of phase
expression of BMP factors and of those inducing Wnt signaling, which allows for the fine regulation
of HF dynamics [41] (Figure 1). Significant findings involving a link between skin and hair follicle
regeneration and EVs have been compiled in Table 1, with emphasis on the signaling pathways that
mediate these effects. It is well established that Wnt factors are master regulators of HF morphogenesis
and hair growth [42]. In fact, epidermal Wnt ligands play a central role in wound-induced de novo hair
formation in adult skin. Hence, they have been pointed out as potential targets for the treatment of
hair-related syndromes like alopecia [43]. On the other hand, active Wnt factors have been identified as
exosome-secreted molecules which can be contained in the interior compartment of these vesicles [44]
as well as transported exteriorly [45]. Several studies have demonstrated that Wnt signaling in recipient
cells can be mediated by horizontal transfer of the proteomic contents of EVs [46]. For instance, EVs
from breast cancer cells have been shown to induce Wnt5a in macrophages, which in turn increases
macrophage-induced invasiveness of the MCF-7 cell line [47]. In addition, Wnt signaling has been
found to be activated in target cells by EVs containing both β-catenin, the major effector protein of
the canonical Wnt pathway, and 14-3-3 proteins [48]. The latter can bind Dvl-2 and GSK-3β, which
in turn mitigates the interaction between GSK-3β and β-catenin, therefore enhancing Wnt signaling.
In fact, both Wnt4 and Wnt11 secreted in exosomes derived from human umbilical cord MSCs have
been proven to benefit cutaneous regeneration in a rat skin burn model. Wnt4 has been found to
enhance Wnt/β-catenin signaling and angiogenesis in the skin [25,49], while the treatment of MSCs
with 3,3′-diindolylmethane has been shown to induce Wnt11 expression in exosomes in an autocrine
fashion, also favoring wound healing through the activation of Wnt/β-catenin signaling [50]. It would
be interesting to further investigate the strong effects of exosome-secreted Wnt11 on hair growth which
have been suggested by the results of this study. In addition, fibroblast-derived exosomes appear to
mobilize Wnt11-mediated autocrine signaling in breast cancer cells, promoting protrusive activity
and motility through the Wnt-planar cell polarity signaling pathway [51]. Interestingly, differential
subsets of Wnt-containing vesicles can be secreted in a distinctive manner in polarized epithelial cells,
a mechanism that has been demonstrated for the release of Wnt3a and Wnt11 in MDCK cells [52] and
which could be of interest in the well-organized architecture of the interfollicular epidermis and HF.
In agreement with these observations, an upregulation in the expression of Wnt3a and Wnt5a, consistent
with hair growth induction, has been found in mouse skin treated with intradermically-injected EVs
obtained from MSCs [53]. Accordingly, exosomes obtained from human DP cells have been found
to extend the anagen phase of the hair cycle by inducing the expression of β-catenin and Sonic
hedgehog (Shh) when injected into mouse skin [54]. Interestingly, in addition to the important role
that Shh signaling plays in hair morphogenesis, its homologous Hh has been shown to be present in
exosome-like vesicles in Drosophila [55].
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MicroRNAs (miRNAs) are small noncoding RNA molecules which are capable of altering gene
expression post transcriptionally and are typically transported in EVs [56,57]. These molecules
have been implicated in the control of skin and HF development through the modulation of Wnt
signaling [58]. In a step forward, miR-181c contained in human umbilical cord MSC-exosomes was
found to be a central player in attenuating burn-induced inflammation in a rat model [59]. Additionally,
exosomes obtained from synovium-MSCs that overexpress miR-126-3p have been found to promote
increased expression of P-AKT and ERK1/2 in HMEC-1 endothelial cells and contribute to skin wound
healing in diabetic rats [27].
Several important signaling pathways involved in key cellular processes such as cell migration,
proliferation, and survival are activated by epidermal growth factor (EGF) ligands binding their
receptors on the plasma membrane. Among these, the routes involving Pi3K/AKT, MAPK/ERK,
STAT3, and IGF1 have been connected with exosome-mediated effects on skin wound healing
or hair growth [21,25,27,28,53]. For instance, the JAK/STAT pathway is implicated in hair
growth [60]. Transforming Growth Factor (TGF)-α belongs to the EGF family and is upstream
of the Grb2/Sos-Ras-Raf-MEK1,2-ERK1,2 signaling cascade, which is widely accepted as a promoter of
cell proliferation [23]. Since mice with TGF-α deficiency display skin and hair abnormalities [61,62],
TGF-α has been implicated in the control of HF shape [42]. TGF-α selectively stimulates hsp90α
exosome-secretion in human keratinocytes, but not in dermal cells [23]. Interestingly, hsp90α
promotes migration of dermal cells even in the presence of the strong inhibitor TGF-β, which is
abundant in the skin wound environment. Thus, hsp90α exosome-secretion by keratinocytes in
response to TGF-α may constitute a major factor stimulating cell motility in the wound bed [23].
In particular, since inhibitory signals mediated by TGF-β family factors are involved in the control
of HF regression (catagen) in vivo [63,64], it would be interesting to investigate whether TGF-α
stimuli can trigger exosome-mediated secretion of hsp90α by HF epithelial cells and affect hair cycle
progression. More work is also needed to determine to what extent the induction in expression of the
apoptosis suppressor BCL-2 in response to MSC-exosomes [53] could participate in the extension of
the anagen phase.
Table 1. The role of extracellular vesicles in signaling pathways with the potential to modulate
hair cycling.
Signaling
Pathway
Molecules
Transported via EVs Source of EVs Highlights of the Study
Model Used to Test the
Effects Ref.
Canonical Wnt
β-catenin and 14-3-3
proteins
HEK293T,
SW480
EV-mediated activation of Wnt
signaling in recipient cells
In vitro: HEK293T,
COS7, SW480 [48]
Wnt4 HuUC-MSCs
HuUC-MSC exosomes facilitated
wound re-epithelization and cell
proliferation through the
activation of Wnt signaling
In vitro: HaCaT,
Ea.hy926, rat dermal
fibroblasts
In vivo: Rat skin 2nd
degree burn injury
[25,49]
Wnt11 HuUC-MSCs
Exosomal Wnt11 autocrine
signaling in response to
3-3′-diindolylmethane increased
markers of stemness in MSCs and
favored wound healing
In vitro: HaCaT, rat
dermal fibroblasts
In vivo: Rat skin 2nd
degree burn injury
[50]
Wnt3a, Wnt11
MDCK,
HEK293,
fibroblast L
cells
Different populations of exosomes
carrying Wnt factors secreted by
epithelial cells depending on the
cell polarity and cell type
[52]
Wnt3a, Wnt5a MouseBM-MSCs
EVs contributed to hair growth in
mice by promoting telogen to
anagen conversion of HFs
In vivo: Mouse skin [53]
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Table 1. Cont.
Signaling
Pathway
Molecules
Transported via EVs Source of EVs Highlights of the Study
Model Used to Test the
Effects Ref.
Wnt-planar cell
polarity Wnt11
Mouse
fibroblast L
cells
Mouse fibroblast-derived
exosomes mobilized
Wnt11-mediated autocrine
signaling, promoting protrusive
activity and motility
In vitro: MDA-MB-231
In vivo: SCID mice [51]
Canonical Wnt;
Shh Not characterized HuDPCs
Exosomes extended the anagen
phase of the hair cycle in mice by
inducing the expression of
β-catenin and Shh
In vivo: Mouse skin [54]
Hh Hh Drosophila Hh transport via exosomes alongcytonems In vitro: Cl8 [55]
TLR4 miR-181c HuUC-MSCs
Exosomes overexpressing
miR-181c reduced burn
inflammation by downregulating
the TLR4 signaling pathway
In vivo: Rat
full-thickness burn
injury
[59]
EGF/EGFR
mi-126-3p HuS-MSCs
Improvement in the healing
capacity of wound dressings by
incorporating exosomes derived
from miR126-overexpressing
HuS-MSCs, which led to the
activation of AKT and ERK1/2
through phosphorylation
In vitro: Human dermal
fibroblast, HMEC-1
In vivo: Full-thickness
excisional skin wound in
diabetic rats
[27]
ERK1/2 BM-MSCs
Key pathways for wound healing
including Akt, ERK, and STAT3,
activated by MSC-exosomes
In vitro: Diabetic versus
normal wound patient
fibroblasts
[21]
ERK1/2 HuEPCs
ERK1/2-mediated improved
angiogenesis in response to
exosomes with beneficial effects
on wound healing
In vitro: HMEC-1
In vivo: Full-thickness
excisional skin wound in
diabetic rats
[28]
TGF-α HKCs
Stimulation of the secretion of
hsp90α in exosomes by
HuK-promoted migration of both
epidermal and dermal cells
In vitro: Primary
neonatal HKCs, dermal
cells
[23]
The table compiles significant findings involving a link between skin and hair follicle regeneration and EVs, with
emphasis on the pathways and the specific signaling molecules mediating these effects. Legend: BM-MSCs, bone
marrow-derived mesenchymal stem cells; EGF, Epidermal Growth Factor; EGFR, Epidermal Growth Factor Receptor;
EV, extracellular vesicles; Hh, Hedgehog; HKCs, human keratinocytes; HuDPCs, human dermal papilla cells;
HuEPCs, human endothelial progenitor cells; HuS-MSCs, human synovium mesenchymal stem cells; HuUC-MSCs,
human umbilical cord mesenchymal stem cells; Shh, Sonic hedgehog; TGF, Transforming Growth Factor.
3.1.2. Use of Extracellular Vesicles to Stimulate Hair Growth: Evidence and Clues
Although only a few studies have focused on the use of exosomes to stimulate hair growth, the
findings in this field are promising. A patented study has provided the first evidence of exosomes
obtained from MSCs being a central component of a pharmaceutical composition directed at enhancing
hair growth [65]. The induction of hair growth was accompanied by an improvement in wound healing,
which is actually not surprising, since both processes have previously been linked by a number of
studies, and different mechanisms involved in this link have been pointed out [66–68]. In agreement
with these observations, subcutaneous administration of conditioned media from human amniotic
fluid-derived MSCs in a full thickness wound model in rats has been found to promote hair regrowth,
together with the acceleration of wound healing [69]. However, only a small number of studies with
several limitations have so far been focused on the characterization of the mechanisms involved in the
beneficial effects of exosomes on hair growth. Importantly, intradermically injected MSC-EVs have
been shown to favor telogen to anagen transition in vivo in a mouse model [44]. An increase in the
expression of proliferation, survival, and migration markers in DP cells treated in vitro with MSC-EVs
was pointed out by the authors as a sign of stimulation, including induced expression of PCNA, P-AKT,
P-ERK, and growth factors such as VEGF and IGF-1. However, since those traits are not typically found
in DP cells over the hair cycle [65], determining the signaling molecules that mediate the induction
of hair growth in response to treatment with EVs in vivo will be key to unequivocally unveiling the
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molecular mechanisms mediating this effect. In a recent study, human DP exosomes were injected into
mouse skin to promote hair growth [54], which can mimic the physiological paracrine effects that DP
cells exert on epithelial cells. An induction in β-catenin and Shh levels was detected in treated skin,
as well as in epithelial hair follicle outer root sheath cells isolated from human scalps and cultured
with DP exosomes. These results consistently revealed the participation of Wnt/β-catenin and Shh
pathways in the molecular mechanisms driving hair growth in response to exosomes. Interestingly,
anagen extension was due not only to a premature anagen onset but also to a delay of the catagen phase
in mice. This suggests that additional molecular mechanisms responsible for hindering the transition
to the catagen stage could be involved in enhanced hair growth. Finally, exosomes containing hTert
have been proven to be secreted by cancer cells and incorporated by telomerase negative fibroblasts,
turning them into nonmalignant cells with telomerase activity [70]. Since HF SC proliferation occurs as
a consequence of conditional telomerase induction [71], hTert-containing exosomes could contribute to
triggering the proliferation of slow-cycling SCs in the HF bulge and favor the transition from telogen
to anagen, ultimately promoting hair growth.
Overall, these observations suggest that since EV cargo has the potential to target a wide range of
molecular processes and recipient cells, EVs emerge as both natural mediators potentially participating
in the control of the hair cycle and promising delivery vehicles for the improvement of skin and hair
regeneration. More work needs to be done in order to determine both the physiological contribution of
exosomes to the HF cycle in vivo and the therapeutic potential of the use of exosomes in the clinics in
order to modulate hair growth.
3.2. Immune System Cells and Hair Follicles
Different types of EVs have been implicated by a myriad of studies in interactions that involve
and affect immune cells [4,72]. Concurrently, important molecules that are released via EVs and
participate in immunomodulation are also recognized as essential factors involved in wound repair [18].
For instance, TGF-β1 belongs to the secretome of mesenchymal stromal cells and is released via
exosomes [73]. Additionally, the extracellular functions carried out by exosome-secreted hsp proteins
include stimulation of immunological cytokine production, activation of antigen-presenting cells,
and anticancer functions [74]. In light of this knowledge, immune cells are indeed key candidates
which participate in the regulation of tissue and hair regeneration as exosome producer or recipient
cells (Figure 2). Hence, therapeutic strategies for hair-related syndromes should also target immune
cell populations. In this sense, several pieces of evidence indicate that important tissue regeneration
processes are mediated by an intimate molecular dialog established between immune cells and other
skin and HF resident cells. For instance, Fgf-9 secreted by γδ-T cells modulates HF neogenesis after
skin wounding in adult mice through the activation of Wnt expression and Wnt signaling in skin
fibroblasts [75]. In addition, regulatory T-cells have also been identified as promoters of proliferation
and differentiation of HF SCs [76]. On the contrary, signals that inhibit hair growth have been
conferred to molecules secreted by immune cells, such as prostaglandin D2 (PGD2), which blocks HF
regeneration through the Gpr44 receptor. This opens up the possibility of therapeutically inhibiting
PGD2 production or Gpr44 signaling to promote skin regeneration [77]. The opposed effects of different
molecules transported via EVs are expected to be controlled depending on the status of the recipient
cells (e.g., the surface receptors being expressed), as well as the tissue microenvironment. In the case
of EVs potentially delivered with therapeutic purposes, the specific molecules loaded as cargo can
be chosen.
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skin homeostasis and repair. Strikingly, exosomes enriched in telomeric repeat-containing RNA 
(TERRA), which are non-coding RNAs that contribute to telomere function, have been identified [79]. 
These TERRA-enriched exosomes have been found to stimulate inflammatory cytokines from 
immune cells and thus have been postulated as telomere-specific alarmins. The authors have 
therefore proposed that TERRA molecules transported by these exosomes work as telomere-specific 
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Figure 2. Extracellular-vesicle-mediated crosstalk between immune cells and hair follicles. EVs can be
naturally produced under physiological/pathological conditions or, alternatively, can be therapeutically
delivered. EVs can contribute to the modulation of hair follicle stem cell function by acting either
directly or indirectly through their effect on immune cells. In this sense, different types of immune
cells are involved in the control of hair follicle dynamics. Skin-resident regulatory T (Treg) cells that
express high levels of the Notch ligand Jagged-1 (Jag1) facilitate hair follicle stem cell function and
contribute to hair follicle regeneration. Skin resident mast cells contribute to hair follicle immune
privilege under physiological conditions but are known to become proinflammatory in alopecia areata,
in which mast cells contain less TGF-β1 and produce exosomes that induce T lymphocytes to proliferate
and secrete cytokines. The γδ-T cell population in mouse skin secretes FGF-9, which modulates hair
follicle neogenesis after skin wounding. In addition, epithelial and dermal hair follicle cells can secrete
EVs that potentially target other hair follicle cell populations or skin resident immune cells, contributing
to the modulation of local inflammation. Purple arrows indicate the flux of EVs; red arrows indicate
proinflammatory stimuli; green T bars indicate anti-inflammatory stimuli.
The importance of the crosstalk between immune cells and skin and HF cells has also been
highlighted by the classification of alopecia areata as an autoimmune disorder involving a switch of
mast cells towards a proinflammatory phenotype [78]. Mast cells in alopecia areata display lower levels
of TGF-β and secrete exosomes that mediate the induction of T-cells to proliferate and increase cytokine
production (Figure 2). This could motivate the use of exosomes for the treatment of autoim une
diseases that affect hair loss, serving as delivery vehicles for signaling molecules that contribute to
the i mune privilege of HFs, for example by facilitating the suppression of major histocompatibility
complex class I molecules or by inducing the expression of immune privilege guardians like TGF-β1/2.
In this context, the use of exosomes as carriers of danger-associated molecular patterns (DAMPs)
and molecules that regulate T-cell function can exert either a direct effect on HF SCs or an indirect
effect through the activation of immune cells involved in the inflammatory response. This can mimic
molecular signals that participate in the activation of skin SCs in response to skin damage, although it
remains unknown whether exoso es are involved in this type of mechanis during physiological
skin homeostasis and repair. Strikingly, exosomes enriched in telomeric repeat-containing RNA
(TERRA), which are non-coding RNAs that contribute to telomere function, have been identified [79].
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These TERRA-enriched exosomes have been found to stimulate inflammatory cytokines from immune
cells and thus have been postulated as telomere-specific alarmins. The authors have therefore proposed
that TERRA molecules transported by these exosomes work as telomere-specific DAMPs which account
for telomeric dysfunction and trigger an inflammatory response in the recipient cells. Given that the HF
bulge SC niche is known to be enriched in cells with relatively longer telomeres [80], this mechanism
could be relevant as a potential way to signal telomere attrition affecting the HF SC compartment,
revealing stem dysfunction and aging, which are linked to hair-related syndromes. Another scenario
where DAMPs could gain importance is in the involution phase of the hair cycle (catagen). This stage is
characterized by synchronic keratinocyte apoptosis in the regressing proximal hair bulb and constitutes
a unique model of dramatic but physiologically programmed epithelial cell death [81]. Since the
release of apoptotic bodies by follicular epithelial cells has been reported [82–84] but their signaling
capacities generally neglected, we propose that new insights into this process could help to understand
the molecular mechanisms that orchestrate hair cycling.
4. Concluding Remarks and Future Directions
The emergent role of EVs in HF dynamics is likely to become a high-impact tool in cosmetic
and skin regenerative biomedicine. In line with recent work revisiting the isolation and purification
methods of different types of EVs [5,45,85], the unification of procedures used to obtain and administer
EVs is needed in order to generate more reliable and comparable data, as well as to implement
novel techniques for the in vivo characterization of EV-driven mechanisms related to HF biology.
In this regard, witty approaches are needed to more deeply explore the physiological and pathological
occurrence of EV crosstalk among different HF subpopulations. Good examples of such strategies are
the two photon approach [86] and the combined intravital microscopy with genetic lineage tracing [87],
which was conceived by Greco’s lab in an attempt to observe the release of exosomes by mutant cells
within the upper portion of the HF and epidermis and their subsequent clearing by both epithelial
and immune cells. In summary, the ease of accessibility of skin may be strongly advantaged with
regard to both the possibility of implementing novel treatments and the potential to serve as a source
of exosome-secreting cells.
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